(ACA) Arcosa - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0396531008

ACA: Aggregates, Construction Equipment, Utility Structures, Wind Towers, Barges, Marine Hardware

Arcosa, Inc. (NYSE:ACA) is a leading provider of infrastructure-related products and solutions, serving the construction, engineered structures, and transportation markets in the United States. The company, incorporated in 2018 and headquartered in Dallas, Texas, operates through three distinct business segments: Construction Products, Engineered Structures, and Transportation Products. Its Construction Products segment supplies natural and recycled aggregates, specialty materials, and construction site support equipment, including trench shields and shoring products, catering to both residential and non-residential construction projects, as well as infrastructure development. The Engineered Structures segment manufactures utility structures, wind towers, traffic and lighting structures, and telecommunication structures, primarily for electricity transmission and distribution, wind power generation, highway construction, and wireless communication markets. This segments products are sold to contractors and distributors who serve state Departments of Transportation and municipal agencies. The Transportation Products segment focuses on inland barges, fiberglass barge covers, winches, marine hardware, and other transportation and industrial equipment, targeting commercial marine transportation companies, lessors, and industrial shippers.

Ticker Symbol: ACA | Exchange: NYSE | Type: Common Stock | Country Origin: United States | GICS Sub Industry: Construction & Engineering

Based on the provided and , the 3-month forecast for Arcosa, Inc. (NYSE:ACA) is as follows: - Technical Outlook: The stock is currently trading at $80.24, above its 20-day SMA ($76.88) but below its 50-day ($82.28) and 200-day ($92.00) moving averages. This indicates potential short-term upside but longer-term resistance near the 200-day SMA. The ATR of 3.35 suggests moderate volatility. - Fundamental Outlook: With a market cap of $3,774.76M, the stock trades at a P/E of 40.52, with a forward P/E of 20.37, indicating expected earnings growth. The P/B ratio of 1.55 and P/S of 1.47 align with industry averages, while the RoE of 3.86% reflects moderate profitability. - Forecast: Over the next three months, ACA is likely to test resistance at $82.28 (50-day SMA) and $92.00 (200-day SMA). Support is expected near $76.88 (20-day SMA). The stock may experience sideways movement with potential upside driven by earnings growth, as implied by the forward P/E. However, the high current P/E ratio may limit near-term appreciation.

Additional Sources for ACA Stock

ACA Stock Overview

Market Cap in USD 3,908m
Sector Industrials
Industry Engineering & Construction
GiC Sub-Industry Construction & Engineering
IPO / Inception 2018-10-30

ACA Stock Ratings

Growth Rating 65.1
Fundamental 11.2
Dividend Rating 29.6
Rel. Strength -3.67
Analysts 4.83/5
Fair Price Momentum 74.11 USD
Fair Price DCF 77.77 USD

ACA Dividends

Dividend Yield 12m 0.23%
Yield on Cost 5y 0.58%
Annual Growth 5y 0.00%
Payout Consistency 96.4%

ACA Growth Ratios

Growth Correlation 3m -82.7%
Growth Correlation 12m 7.3%
Growth Correlation 5y 86.6%
CAGR 5y 18.52%
CAGR/Max DD 5y 0.51
Sharpe Ratio 12m -0.24
Alpha -10.66
Beta 1.567
Volatility 33.18%
Current Volume 327.8k
Average Volume 20d 288.4k
What is the price of ACA stocks?
As of May 01, 2025, the stock is trading at USD 80.07 with a total of 327,756 shares traded.
Over the past week, the price has changed by +2.30%, over one month by +3.89%, over three months by -20.91% and over the past year by +5.57%.
Is Arcosa a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Arcosa is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 11.19 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACA as of May 2025 is 74.11. This means that ACA is currently overvalued and has a potential downside of -7.44%.
Is ACA a buy, sell or hold?
Arcosa has received a consensus analysts rating of 4.83. Therefor, it is recommend to buy ACA.
  • Strong Buy: 5
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ACA stock price target?
According to ValueRays Forecast Model, ACA Arcosa will be worth about 83.5 in May 2026. The stock is currently trading at 80.07. This means that the stock has a potential upside of +4.33%.
Issuer Forecast Upside
Wallstreet Target Price 111.8 39.7%
Analysts Target Price 116 44.9%
ValueRay Target Price 83.5 4.3%